Medicare spending analysis for Hematology providers
Hematology accounts for $980.0M in Medicare payments across 7.6K providers.
The specialty's average markup of 3.8x is above the overall Medicare average of 3.77x.
AI-generated analysis based on Medicare payment data.
| Year | Payments | Services | Providers | YoY Change |
|---|---|---|---|---|
| 2014 | $107.3M | 8.6M | 702 | — |
| 2015 | $93.9M | 7.8M | 697 | -12.6% |
| 2016 | $97.6M | 8.5M | 689 | +4.0% |
| 2017 | $95.7M | 7.5M | 708 | -2.0% |
| 2018 | $105.9M | 8.3M | 745 | +10.6% |
| 2019 | $108.0M | 8.9M | 770 | +2.0% |
| 2020 | $94.0M | 7.3M | 778 | -12.9% |
| 2021 | $95.8M | 6.2M | 804 | +1.9% |
| 2022 | $86.2M | 5.4M | 827 | -10.0% |
| 2023 | $95.5M | 5.7M | 873 | +10.8% |
| # | Provider | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|
| 1 | Carl Gray | UT | $3.9M | 239.1K | $16.14 |
| 2 | Andrew Mener | MD | $3.5M | 207.7K | $16.69 |
| 3 | Leonard Hackett | CA | $3.3M | 319.6K | $10.45 |
| 4 | Frederick Min | MD | $3.2M | 286.4K | $11.09 |
| 5 | Jamie Burton | AR | $2.8M | 170.1K | $16.61 |
| 6 | Stanley Schinke | CA | $2.8M | 251.5K | $11.20 |
| 7 | Sreedevi Daggubati | TX | $2.8M | 254.6K | $11.04 |
| 8 | Youram Nassir | CA | $2.7M | 246.3K | $11.02 |
| 9 | Myron Bednar | NJ | $2.5M | 177.7K | $14.21 |
| 10 | Amishi Desai | NY | $2.2M | 253.9K | $8.83 |
| 11 | Haiyun Wang | PA | $2.0M | 138.5K | $14.44 |
| 12 | John Devlin | PA | $2.0M | 185.9K | $10.64 |
| 13 | Allison Rosenthal | AZ | $1.9M | 100.8K | $18.83 |
| 14 | Jayesh Mehta | IL | $1.9M | 73.8K | $25.27 |
| 15 | Samarth Reddy | FL | $1.8M | 106.1K | $17.16 |
| 16 | Richard Ingram | VA | $1.7M | 76.0K | $22.71 |
| 17 | Shuo Ma | IL | $1.3M | 59.2K | $22.71 |
| 18 | Jumana Chatiwala | NJ | $1.3M | 171.7K | $7.69 |
| 19 | Leo Gordon | IL | $1.1M | 44.1K | $24.51 |
| 20 | Rene Rubin | PA | $1.1M | 42.4K | $24.85 |
| 21 | Pouyan Changizzadeh | CT | $1.1M | 64.5K | $16.29 |
| 22 | Lena Dumasia | PA | $1.0M | 38.6K | $26.69 |
| 23 | Stavroula Otis | CA | $933.7K | 121.9K | $7.66 |
| 24 | Neelesh Bangalore | CA | $894.5K | 43.4K | $20.60 |
| 25 | Saurabh Das | OH | $885.1K | 33.6K | $26.34 |
| Code | Description | Payments | Services | Avg/Service |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | $15.4M | 362.4K | $42.46 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | $13.5M | 158.3K | $85.47 |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | $9.4M | 79.4K | $118.86 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | $6.6M | 175.0K | $37.53 |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | $5.8M | 60.1K | $96.69 |
| J0897 | Injection, denosumab, 1 mg | $5.8M | 314.4K | $18.37 |
| J9299 | Injection, nivolumab, 1 mg | $4.5M | 189.8K | $23.57 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | $2.7M | 46.7K | $57.50 |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | $2.3M | 15.1K | $151.44 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | $2.0M | 18.7K | $108.40 |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | $1.9M | 28.6K | $64.88 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | $1.6M | 45.4K | $35.62 |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | $1.3M | 9.4K | $139.51 |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | $1.3M | 38.9K | $33.25 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | $1.1M | 484.6K | $2.35 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | $917.9K | 1.1M | $0.87 |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | $844.6K | 7.5K | $112.31 |
| Q5126 | Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg | $755.1K | 13.7K | $54.99 |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | $729.1K | 6.9K | $106.29 |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | $697.2K | 527 | $1.3K |
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.